Cite Filings / WGS / 0001818331-25-000010
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

GeneDx Holdings Corp. · Filed 2025-01-29 · Acc 0001818331-25-000010

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2025-02-05 SCHEDULE 13G Statement of Beneficial Ownership
  • 2025-01-31 4 CHIEF FINANCIAL OFFICER sold 275 shares at $78.48 ($21,582)
  • 2025-01-31 4 Chief Executive Officer sold 1,657 shares at $78.48 ($130,046)
  • 2025-01-30 144 Sale of Securities
  • 2025-01-29 144 Sale of Securities
  • 2025-01-29 144 Sale of Securities
  • 2025-01-22 4 Director acquired 3,000 shares (option exercise)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…